2025 Europe Artificial Intelligence (Ai) In Diagnostics Market Revenue Opportunities Report
Description
The 2025 Europe Artificial Intelligence (Ai) In Diagnostics Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Artificial Intelligence (AI) In Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Artificial Intelligence (AI) in Diagnostics Market in Europe are Siemens Healthineers, DeepMind, Roche, and IBM. Siemens Healthineers, headquartered in Germany, leads with advanced AI-powered medical imaging solutions such as AI-Rad Companion and AI-Pathway Companion that enhance radiology diagnostics and clinical decision support, integrating AI across imaging modalities and therapy planning. DeepMind, now part of Google Health, pioneers AI in disease detection algorithms, notably collaborating with Moorfields Eye Hospital to develop AI systems for eye disease diagnosis with high accuracy rates. Roche collaborates with startups like Mindpeak to integrate AI in digital pathology, boosting personalized cancer diagnostics and patient care in Europe.
IBM is recognized for its focus on responsible AI ethics, developing trustworthy AI applications that enhance transparency in healthcare diagnostics. Additionally, startups such as Ultromics (Oxford-based) and Corti (Denmark) complement these giants by offering AI systems for early cardiovascular disease prediction and emergency cardiac arrest detection, respectively, demonstrating Europe's broader active landscape in AI diagnostics. Siemens Healthineers and Roche's collaborations and DeepMind and IBM's innovations position these companies at the forefront of AI integration in Europe's diagnostic healthcare market.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Artificial Intelligence (AI) In Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Artificial Intelligence (AI) in Diagnostics Market in Europe are Siemens Healthineers, DeepMind, Roche, and IBM. Siemens Healthineers, headquartered in Germany, leads with advanced AI-powered medical imaging solutions such as AI-Rad Companion and AI-Pathway Companion that enhance radiology diagnostics and clinical decision support, integrating AI across imaging modalities and therapy planning. DeepMind, now part of Google Health, pioneers AI in disease detection algorithms, notably collaborating with Moorfields Eye Hospital to develop AI systems for eye disease diagnosis with high accuracy rates. Roche collaborates with startups like Mindpeak to integrate AI in digital pathology, boosting personalized cancer diagnostics and patient care in Europe.
IBM is recognized for its focus on responsible AI ethics, developing trustworthy AI applications that enhance transparency in healthcare diagnostics. Additionally, startups such as Ultromics (Oxford-based) and Corti (Denmark) complement these giants by offering AI systems for early cardiovascular disease prediction and emergency cardiac arrest detection, respectively, demonstrating Europe's broader active landscape in AI diagnostics. Siemens Healthineers and Roche's collaborations and DeepMind and IBM's innovations position these companies at the forefront of AI integration in Europe's diagnostic healthcare market.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
